CIK 0000109657
- Non-accelerated filer
- Smaller reporting company
GT Biopharma, Inc.
Sign in to watch- Ticker
- GTBP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 941620407
- Phone
- +1 800-304-9888
- Business address
- 505 MONTGOMERY STREET, 10TH FLOOR, SAN FRANCISCO, CA, 94111
- Former names
- GT Biopharma, Inc., OXIS INTERNATIONAL INC
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Director sold 700,000 shares at an average $0.13 ($91,396)
- 4 Open-market sale 10% owner sold 700,000 shares at an average $0.13 ($91,396)
- 3/A Insider 3/A
- 3/A Insider 3/A
- 4 Open-market sale Former Director and Secretary sold 69,600 shares at $0.11 ($7,733)
- 4 Open-market sale Former Director and Secretary sold 107,000 shares at an average $0.12 ($12,378)
- 4 Open-market sale Secretary sold 423,400 shares at an average $0.10 ($43,905)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 1,500,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 5 Insider Annual Insider Trading Report
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 4 of 8 · 160 filings